All of Your Recall News And Alerts In One Easy To Use Place Or Sent To You By Email

Clinicians should consider the potential long-term risks when prescribing to adolescents.
This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.
View Full Details Of The Original MedWatch Notice Here.

Clinically significant fluid imbalance and potential for users to repeatedly override the fluid imbalance alarm.
This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.
View Full Details Of The Original MedWatch Notice Here.

Class I recall due to “coring” or dislodging of silicone cores or slivers from the ports into which they are inserted.
This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.
View Full Details Of The Original [...]

UPDATE [01/23/2010] Previous alert updated with information on laboratory analysis of sibutramine levels in counterfeit product – Product sold over the internet contains controlled substance sibutramine.
This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.
View [...]